Home Knight Therapeutics

Knight Therapeutics

In operation
Post-IPO Round
Professional Pharmaceutical Company
Basic
Enterprise Profile

Basic Information

Knight Therapeutics Inc., headquartered in Montreal, Canada, is a specialty pharmaceutical company focused on acquiring or licensing innovative pharmaceuticals for the Canadian and global markets. Knight Therapeutics' stock began trading on the TSX-V on March 3, 2014, under the symbol GUD.
Knight Therapeutics Inc.
Quebec,Canada
15~50 people
January 01, 1995
info@gud-knight.com

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Chemical Pharmaceutical Preparations Operations Management Biological Drug Production
Concept
Disease Treatment
Application Scenarios
Innovative Drugs